Tuberous sclerosis: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 13: Line 13:


{{SK}} Tuberous sclerosis complex, TSC, Bourneville disease, Bourneville-Pringle syndrome, epiloia
{{SK}} Tuberous sclerosis complex, TSC, Bourneville disease, Bourneville-Pringle syndrome, epiloia
==[[Tuberous sclerosis overview|Overview]]==
==[[Tuberous sclerosis historical perspective|Historical Perspective]]==
==[[Tuberous sclerosis classification|Classification]]==
==[[Tuberous sclerosis pathophysiology|Pathophysiology]]==
==[[Tuberous sclerosis causes|Causes]]==
==[[Tuberous sclerosis differential diagnosis|Differentiating Tuberous sclerosis from other Diseases]]==
==[[Tuberous sclerosis epidemiology and demographics|Epidemiology and Demographics]]==
==[[Tuberous sclerosis risk factors|Risk Factors]]==
==[[Tuberous sclerosis natural history, complications and prognosis|Natural History, Complications and Prognosis]]==
==Diagnosis==
[[Tuberous sclerosis history and symptoms|History and Symptoms]] | [[Tuberous sclerosis physical examination|Physical Examination]] | [[Tuberous sclerosis laboratory findings|Laboratory Findings]] | [[Tuberous sclerosis electrocardiogram|Electrocardiogram]] | [[Tuberous sclerosis CT|CT]] | [[Tuberous sclerosis MRI|MRI]] | [[Tuberous sclerosis ultrasound|Ultrasound]] | [[Tuberous sclerosis other imaging findings|Other Imaging Findings]] | [[Tuberous sclerosis other diagnostic studies|Other Diagnostic Studies]]
==Treatment==
[[Tuberous sclerosis medical therapy|Medical Therapy]] | [[Tuberous sclerosis surgery|Surgery]] | [[Tuberous sclerosis primary prevention|Primary Prevention]] | [[Tuberous sclerosis secondary prevention|Secondary Prevention]] | [[Tuberous sclerosis cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Tuberous sclerosis future or investigational therapies|Future or Investigational Therapies]]
==Case Studies==
[[Tuberous sclerosis case study one|Case #1]]





Revision as of 18:42, 27 February 2013

Tuberous sclerosis
Earliest illustration, from Rayer's atlas of skin diseases, 1835.

Tuberous sclerosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Differentiating Tuberous sclerosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Tuberous sclerosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Tuberous sclerosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Tuberous sclerosis

CDC on Tuberous sclerosis

Tuberous sclerosis in the news

Blogs on Tuberous sclerosis

Directions to Hospitals Treating Tuberous sclerosis

Risk calculators and risk factors for Tuberous sclerosis

For patient information on this page, click here

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Raviteja Guddeti, M.B.B.S. [2]

Synonyms and keywords: Tuberous sclerosis complex, TSC, Bourneville disease, Bourneville-Pringle syndrome, epiloia

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Tuberous sclerosis from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | CT | MRI | Ultrasound | Other Imaging Findings | Other Diagnostic Studies

Treatment

Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies

Case Studies

Case #1


Template:Phakomatoses and other congenital malformations not elsewhere classified


Template:WikiDoc Sources